Martin Krsak, MD

Research Interests

Publications

• Krsak M, Trowbridge P, Regan N, Freedman KI (2017) Buprenorphine with, or without, Naloxone for Pregnant Women?–Review of Current Evidence and Practice in Massachusetts. J Alcohol Drug Depend 5: 269
• Krsak M, Patel NU, Poeschla EM. Case Report: Hepatic Fascioliasis in a Young Afghani Woman with Severe Wheezing, High-Grade Peripheral Eosinophilia, and Liver Lesions: A Brief Literature Review. Am J Trop Med Hyg. 2019 Mar;100(3):588-590. PubMed PMID: 30628571
• Krsak M, Damioli L. Is 2 Weeks of Treatment Enough for Cortical Bone Osteomyelitis?. Clin Infect Dis. 2020 Jan 1;70(1):179. PubMed PMID: 31069382
• Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs. Open Forum Infect Dis. 2019 Jul;6(7):ofz274. PubMed PMID: 31281868
• Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections. J Antimicrob Chemother. 2019 Aug 1;74(8):2405-2416. PubMed PMID: 31322694
• Krsak M, Montague BT, Trowbridge P, Johnson SC, Binswanger IA. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. J Infect Dis. 2020 Sep 2;222(Supplement_5):S486-S493. PubMed PMID: 32877543
• Krsak M, Morrisette T, Miller M, Molina K, Huang M, Damioli L, Pisney L, Wong M, Poeschla E. Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A Review. Pharmacotherapy. 2020 May;40(5):469-478. PubMed PMID: 32239771
• Franco-Paredes C, Jankousky K, Schultz J, Bernfeld J, Cullen K, Quan NG, Kon S, Hotez P, Henao-Martínez AF, Krsak M. COVID-19 in jails and prisons: A neglected infection in a marginalized population. PLoS Negl Trop Dis. 2020 Jun;14(6):e0008409. PubMed PMID: 32569274
• Krsak M, Johnson SC, Poeschla EM. COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions. Am J Trop Med Hyg. 2020 Jun;102(6):1189-1190. PubMed PMID: 32329432
• Krsak M, Henao-Martínez AF, Franco-Paredes C. Screening for Covid-19 in Skilled Nursing Facilities. N Engl J Med. 2020 Jul 9;383(2):190-191. PubMed PMID: 32469480
• Canfield GS, Schultz JS, Windham S, Scherger S, Henao-Martinez AF, Shapiro L, Franco-Paredes C, Chastain DB, Wand T, Krsak M. Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of History. J Hosp Med. 2020 Jul 1;15(7):434-436. PubMed PMID: 32584243
• Krsak M, Jeffers A, Shah J, Johnson SC, Montague BT. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado. Telemed J E Health. 2019 Sep 5. [Epub ahead of print] PubMed PMID: 31486710
• Solis J, Franco-Paredes C, Henao-Martínez AF, Krsak M, Zimmer SM. Structural Vulnerability in the U.S. Revealed in Three Waves of COVID-19. Am J Trop Med Hyg. 2020 Jul;103(1):25-27. PubMed PMID: 32383432
• Krsak M, Kent DM, Terrin N, Holcroft C, Skinner SC, Wanke C. Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins. AIDS Patient Care STDS. 2015 Jun;29(6):307-13. PubMed PMID: 25855882
• Krsak M, Wada NI, Plankey MW, Kinney GL, Epeldegui M, Okafor CN, Friedman MR, Palella FJ, Erlandson KM. Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV. Cannabis and Cannabinoid Research http://doi.org/10.1089/can.2019.0083 [Online ahead of print – 3/24/2020]
• Krsak M, Henao-Martínez AF, Franco-Paredes C. COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunology. (Online Ahead of Print: November 11, 2020), http://doi.org/10.1089/vim.2020.0246
• Franco-Paredes C, Ghandnoosh N, Latif H, Krsak M, Henao-Martinez AF, Robins M, Vargas Barahona L, Poeschla EM. Decarceration and community re-entry in the COVID-19 era. Lancet Infect Dis. 2020 Sep 29:S1473-3099(20)30730-1. doi: 10.1016/S1473-3099(20)30730-1. Epub ahead of print. PMID: 33007225; PMCID: PMC7524519.
• Krsak M, Henao-Martínez AF, Franco-Paredes C. COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunol. 2020 Nov 11. [Epub ahead of print] PubMed PMID: 33181055
• Franco-Paredes C, Ghandnoosh N, Latif H, Krsak M, Henao-Martinez AF, Robins M, Vargas Barahona L, Poeschla EM. Decarceration and community re-entry in the COVID-19 era. Lancet Infect Dis. 2021 Jan;21(1):e11-e16. PubMed PMID: 33007225
• Krsak M, Montague BT, Trowbridge P, Johnson SC, Binswanger IA. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. J Infect Dis. 2020 Sep 2;222(Supplement_5):S486-S493. PubMed PMID: 32877543
• Canfield GS, Schultz JS, Windham S, Scherger S, Henao-Martinez AF, Shapiro L, Franco-Paredes C, Chastain DB, Wand T, Krsak M. Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of History. J Hosp Med. 2020 Jul 1;15(7):434-436. PubMed PMID: 32584243
• Franco-Paredes C, Jankousky K, Schultz J, Bernfeld J, Cullen K, Quan NG, Kon S, Hotez P, Henao-Martínez AF, Krsak M. COVID-19 in jails and prisons: A neglected infection in a marginalized population. PLoS Negl Trop Dis. 2020 Jun;14(6):e0008409. PubMed PMID: 32569274
• Krsak M, Henao-Martínez AF, Franco-Paredes C. Screening for Covid-19 in Skilled Nursing Facilities. N Engl J Med. 2020 Jul 9;383(2):190-191. PubMed PMID: 32469480
• Solis J, Franco-Paredes C, Henao-Martínez AF, Krsak M, Zimmer SM. Structural Vulnerability in the U.S. Revealed in Three Waves of COVID-19. Am J Trop Med Hyg. 2020 Jul;103(1):25-27. PubMed PMID: 32383432
• Krsak M, Johnson SC, Poeschla EM. COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions. Am J Trop Med Hyg. 2020 Jun;102(6):1189-1190. PubMed PMID: 32329432
• Krsak M, Morrisette T, Miller M, Molina K, Huang M, Damioli L, Pisney L, Wong M, Poeschla E. Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A Review. Pharmacotherapy. 2020 May;40(5):469-478. PubMed PMID: 32239771
• Krsak M, Jeffers A, Shah J, Johnson SC, Montague BT. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado. Telemed J E Health. 2020 Jun;26(6):776-783. PubMed PMID: 31486710
• Krsak M, Damioli L. Is 2 Weeks of Treatment Enough for Cortical Bone Osteomyelitis?. Clin Infect Dis. 2020 Jan 1;70(1):179. PubMed PMID: 31069382
• Krsak M, Wada NI, Plankey MW, Kinney GL, Epeldegui M, Okafor CN, Friedman MR, Palella FJ, Erlandson KM. Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV. Cannabis and Cannabinoid Research http://doi.org/10.1089/can.2019.0083 [Online ahead of print – 3/24/2020]
• Molina KC, Miller MA, Mueller SW, Van Matre ET, Krsak M, Kiser TH. Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin. Clin Pharmacokinet. 2021 Dec 21. [Epub ahead of print] PubMed PMID: 34931283
• Krsak M, Harry BL, Palmer BE, Franco-Paredes C. Response to Mishra et al . re "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2". Viral Immunol. 2021 Nov;34(9):659-660. PubMed PMID: 34672802
• Viszlayová D, Sojka M, Dobrodenková S, Szabó S, Bilec O, Turzová M, Durina J, Baloghová B, Borbély Z, Kršák M. SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID. Ther Adv Infect Dis. 2021 Jan-Dec;8:20499361211048572. PubMed PMID: 34659752
• Rosolanka R, Henao-Martinez AF, Pisney L, Franco-Paredes C, Krsak M. COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures. Ther Adv Infect Dis. 2021 Jan-Dec;8:20499361211032039. PubMed PMID: 34349986
• Krsak M, Harry BL, Palmer BE, Franco-Paredes C. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2. Viral Immunol. 2021 Oct;34(8):504-509. PubMed PMID: 34227891
• Krsak M, Wada NI, Plankey MW, Kinney GL, Epeldegui M, Okafor CN, Friedman MR, Palella FJ, Erlandson KM. Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV. Cannabis Cannabinoid Res. 2021 Apr;6(2):165-173. PubMed PMID: 33912681
• Mueller SW, Kedzior SK, Miller MA, Reynolds PM, Kiser TH, Krsak M, Molina KC. An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections. Expert Opin Pharmacother. 2021 Jul;22(10):1355-1371. PubMed PMID: 33878996
• Quan NG, Latif H, Krsak M, Corbisiero MF, Solis J, Wand T, Mortaji P, Vrolijk MA, Kon S, Ghandnoosh N, Franco-Paredes C. Benefits of COVID-19 viral screening of formerly incarcerated individuals during community reentry. Ther Adv Infect Dis. 2021 Jan-Dec;8:2049936120985951. PubMed PMID: 33505680
• Krsak M, Henao-Martínez AF, Franco-Paredes C. COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunol. 2021 Apr;34(3):130-133. PubMed PMID: 33181055
• Franco-Paredes C, Ghandnoosh N, Latif H, Krsak M, Henao-Martinez AF, Robins M, Vargas Barahona L, Poeschla EM. Decarceration and community re-entry in the COVID-19 era. Lancet Infect Dis. 2021 Jan;21(1):e11-e16. PubMed PMID: 33007225
• Laper S, Hileman CO, Block G, Erlandson KM, Krsak M. Perceived Risks and Benefits and Frequency of Cannabis Use Among People with HIV in Different Legal Environments. AIDS Res Hum Retroviruses. 2023 Nov 6. [Epub ahead of print] PubMed PMID: 37823750
• Cortes-Penfield N, Krsak M, Damioli L, Henry M, Seidelman J, Hewlett A, Certain L. How we approach suppressive antibiotic therapy (SAT) following debridement, antibiotics, and implant retention for prosthetic joint infection. Clin Infect Dis. 2023 Aug 17. [Epub ahead of print] PubMed PMID: 37590953
• Mueller SW, Blass B, Molina KC, Gibson C, Krsak M, Kohler AD, Deeter L, Stalilonis J, Wiktor AJ. Augmented Renal Function in Burn Patients: Occurrence and Discordance With Commonly Used Methods to Assess Renal Function. J Burn Care Res. 2023 Nov 2;44(6):1298-1303. PubMed PMID: 37450897
• Coyle DT, Stewart S, Bortz C, Manalo J, Ritvo A, Krsak M. Buprenorphine Prescribing and Dosing Limits: Evidence and Policy Goals. Subst Abus. 2023 Jan-Apr;44(1):17-23. PubMed PMID: 37226901
• Molina KC, Mueller SW, Miller MA, Krsak M. Response to Mahatanan and Kang: It's Complicated. Open Forum Infect Dis. 2023 May;10(5):ofad210. PubMed PMID: 37180593
• Texidor WM, Miller MA, Molina KC, Krsak M, Calvert B, Hart C, Storer M, Fish DN. Oritavancin as Sequential Therapy for Gram-positive Bloodstream Infections, 18 July 2023, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-3102101/v1]

Practice Locations

• University of Colorado Hospital

Specialty Information

• Internal Medicine, Board Certification (2011, 2011)
• Infectious Disease, Board Certification (2013, 2013)
• Addiction Medicine, Board Certification (2018, 2018)
• DATA 2000 Waiver, Specialized Training (2015)

• Infections
• Substance Abuse